ProMIS Neurosciences Inc. Common Shares (ON)
PMN CA74346M4065
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Milbury Max A. |
0.49 USD |
30,392 Bought |
14,929 USD |
03/10/2025 | 03/10/2025 |
| Cashman Neil CSO |
0.97 USD |
15,000 Bought |
14,595 USD |
10/02/2025 | 10/02/2025 |
| Shafmaster Madge K. |
1.30 USD |
70,000 Bought |
91,028 USD |
20/09/2024 | 24/09/2024 |
| Shafmaster Madge K. |
1.28 USD |
70,000 Bought |
89,656 USD |
20/09/2024 | 23/09/2024 |
| Shafmaster Madge K. |
1.25 USD |
60,000 Bought |
75,066 USD |
20/09/2024 | 20/09/2024 |
| Gordon Michael S O |
1.40 USD |
16,292 Bought |
22,809 USD |
16/09/2024 | 17/09/2024 |
| Gordon Michael S O |
1.22 USD |
76,931 Bought |
94,071 USD |
16/09/2024 | 16/09/2024 |
| Kirwin Patrick D. |
1.25 USD |
10,000 Bought |
12,492 USD |
14/08/2024 | 14/08/2024 |